Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15716 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Kaiyi Mao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Antiviral Agents, Pregnancy Complications, Infectious, Pregnancy Outcome, Hepatitis B. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, China, The National Key Clinical Specialty Construction Projects of Fujian Province, China.
Abstract (Originalsprache)
Objective
To explore the relationships between gestational hepatitis B virus (HBV) infection, antiviral therapy, and pregnancy outcomes.
Methods
We retrospectively selected hepatitis B surface antigen (HBsAg)‐positive pregnant women hospitalized for delivery at Fujian Medical University Affiliated Hospital from October 1, 2016 to October 1, 2020. The control group included randomly selected healthy pregnant women hospitalized for delivery during the same time.
Results
Overall, 1115 participants were enrolled and grouped into control ( n = 380) and HBsAg‐positive groups ( n = 735), which were further divided into groups I ( n = 407; low viral load), II ( n = 207; high viral load without antiviral therapy), and III ( n = 121; high viral load with antiviral therapy). Pregnant women with HBV were positively correlated with the incidence of intrahepatic cholestasis of pregnancy (ICP) (adjusted odds ratio [aOR] 5.1, 95% confidence interval [CI] 2.62–9.92, P < 0.001), neonatal jaundice (aOR 10.56, 95% CI 4.49–24.83, P < 0.001), and neonatal asphyxia (aOR 5.03, 95% CI 1.46–17.27, P = 0.01). Aspartate aminotransferase (AST) greater than the upper limit of normal (ULN) was an independent risk factor for increased ICP incidence (aOR 3.49, 95% CI 1.26–9.67, P = 0.019). Antiviral therapy considerably reduced HBV DNA and improved liver function. High viral load and antiviral therapy did not correlate significantly with adverse pregnancy outcomes ( P < 0.05).
Conclusion
Pregnant women with HBV have significantly elevated incidence of ICP, neonatal jaundice, and neonatal asphyxia not significantly correlated with viral load. AST greater than ULN independently increases the risk of ICP. Antiviral therapy effectively reduces viral replication and improves liver function without increasing the risk of adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Obstetrics and Gynecology, Fujian Medical University Union Hospital, Fuzhou, China.
- Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, Fuzhou, China.
ORCID-Profile: Dan Li
Förderung
- Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, China
- The National Key Clinical Specialty Construction Projects of Fujian Province, China
Zitieren
APA
Mao, K., Jiang, P., Cai, W., Lin, Y., Zhou, Y., & Li, D. (2024). Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15716
Vancouver
Mao K, Jiang P, Cai W, Lin Y, Zhou Y, Li D. Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15716
BibTeX
@article{Mao2024,
author = {Mao, Kaiyi and Jiang, Pingying and Cai, Weiqi and Lin, Yongxu and Zhou, Yu and Li, Dan},
title = {Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15716}
}
EUVIMED